CloudCath Announces $12 Million Series A Financing for Technology Enabling Remote, Real-Time Complication Monitoring for At-Home Dialysis

Feb 14, 2020•over 5 years ago

Amount Raised

$12 Million

Round Type

series a

San Francisco

Description

CloudCath, a company dedicated to remote complication monitoring for patients undergoing catheter-based treatments, today announced that it has completed a $12 million Series A financing led by Capital Integral with participation from FundRx, The Capital Partnership, Coconut Tree Investments, Stanford University’s StartX Fund, and additional strategic and individual investors. Proceeds from the round will be used to commercialize CloudCath’s first product, a system that enables remote, real-time monitoring for patients undergoing at-home peritoneal dialysis, allowing earlier complication intervention. Funding will also support the development of additional applications utilizing the company’s proprietary technology.

Company Information

Company

Cloud Cath

Location

San Francisco, California, United States

About

Founded in 2017, CloudCath is a digital health medical device company that is dedicated to remote complication monitoring for patients undergoing catheter-based treatments. Its remote monitoring platform analyzes drainage fluid, utilizing proprietary data analysis algorithms to detect fluid property deviations, and automatically transmits notifications to healthcare providers, enabling earlier intervention in cases of catheter-associated complications like infection. CloudCath’s first product is designed for patients undergoing peritoneal dialysis.

FundzWatch™ Score

Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data

Tech investment trends